Added to YB: 2017-04-04
Pitch date: 2017-04-04
BLCM [bullish]
Bellicum Pharmaceuticals, Inc.
-99.91%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Bellicum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally.
Market Cap
EUR 811.5K
Pitch Price
EUR 84.70
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.11
P/E
-0.10
EV/Sales
17.59
Sector
Biotechnology
Category
N/A
Show full summary:
Bellicum Pharmaceuticals, Inc. BLCM
A summary for this pitch has not been created yet.
Read full article (0 min)